Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva Ruchika Sharma23 Sept 2025 11:24 AM ISTHyderabad: Dr Reddy's Laboratories Ltd., has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
New tracer could enable surgeons to see and hear prostate cancer: Study Dr. Kamal Kant Kohli19 Sept 2025 11:00 PM ISTA preclinical evaluation of a new 'dual-mode' tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but...
Lower Irisin Levels Linked to Diabetic Nephropathy Progression in T2DM: Study Dr. Shravani Dali18 Sept 2025 11:00 AM ISTA newly published study suggests that lower circulating irisin levels in patients with type 2 diabetes (T2DM) are associated with impaired renal...
Vasectomy More Cost-Effective Than Salpingectomy for Permanent Contraception, Reveals Research Medha Baranwal15 Sept 2025 10:30 PM ISTUSA: Researchers have found in a new cost-effectiveness analysis that vasectomy is a more cost-effective permanent contraceptive option. While...
FDA Approves INLEXZO for BCG-Unresponsive Bladder Cancer Dr. Kamal Kant Kohli15 Sept 2025 8:30 PM ISTThe U.S. FDA has approved Johnson & Johnson's INLEXZO (gemcitabine intravesical system) for adults with BCG-unresponsive non-muscle invasive...
Rheumatoid Arthritis Patients Face Higher Risk of Kidney Stones: Study Dr. Shravani Dali14 Sept 2025 9:00 PM ISTKidney stone disease remains a growing health concern worldwide, with metabolic, inflammatory, and lifestyle factors all contributing to risk. New...
Biparametric MRI Effective as Multiparametric MRI in Detecting Prostate Cancer: Study Jacinthlyn Sylvia14 Sept 2025 9:00 PM ISTA recent study published in the Journal of the American Medical Association found biparametric MRI to performs just as well as the current...
Millions of men could benefit from faster scan to diagnose prostate cancer: JAMA Dr. Kamal Kant Kohli12 Sept 2025 8:45 PM ISTA quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI...
SOX2: a key player in prostate cancer progression and treatment resistance: Study Dr. Kamal Kant Kohli11 Sept 2025 8:00 PM ISTProstate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage disease can be...
Steroidal MRAs Ineffective and Risky in Kidney Transplant Recipients: Study Dr. Shravani Dali10 Sept 2025 9:30 PM ISTResearchers have found in a new study steroidal mineralocorticoid receptor antagonists (MRAs) show no superior efficacy over placebo in kidney...
Penile Implant Satisfaction Drops in Prostate Cancer Patients on Hormonal Treatment, reveals study Dr. Kamal Kant Kohli10 Sept 2025 8:45 PM ISTProstate cancer is the most common malignancy among men, with over 160,000 new cases diagnosed annually in the United States. Although advances in...
JnJ bags USFDA nod for bladder cancer treatment Inlexzo Ruchika Sharma10 Sept 2025 11:46 AM ISTRaritan: Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for INLEXZO (gemcitabine intravesical...
